PT - JOURNAL ARTICLE AU - Jeremy R. McGarvey AU - Sara Pettaway AU - James A. Shuman AU - Craig P. Novack AU - Kia N. Zellars AU - Parker D. Freels AU - Randall L. Echols, Jr AU - Jason A. Burdick AU - Joseph H. Gorman III AU - Robert C. Gorman AU - Francis G. Spinale TI - Targeted Injection of a Biocomposite Material Alters Macrophage and Fibroblast Phenotype and Function following Myocardial Infarction: Relation to Left Ventricular Remodeling AID - 10.1124/jpet.114.215798 DP - 2014 Sep 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 701--709 VI - 350 IP - 3 4099 - http://jpet.aspetjournals.org/content/350/3/701.short 4100 - http://jpet.aspetjournals.org/content/350/3/701.full SO - J Pharmacol Exp Ther2014 Sep 01; 350 AB - A treatment target for progressive left ventricular (LV) remodeling prevention following myocardial infarction (MI) is to affect structural changes directly within the MI region. One approach is through targeted injection of biocomposite materials, such as calcium hydroxyapatite microspheres (CHAM), into the MI region. In this study, the effects of CHAM injections upon key cell types responsible for the MI remodeling process, the macrophage and fibroblast, were examined. MI was induced in adult pigs before randomization to CHAM injections (20 targeted 0.1-ml injections within MI region) or saline. At 7 or 21 days post-MI (n = 6/time point per group), cardiac magnetic resonance imaging was performed, followed by macrophage and fibroblast isolation. Isolated macrophage profiles for monocyte chemotactic macrophage inflammatory protein-1 as measured by real-time polymerase chain reaction increased at 7 days post-MI in the CHAM group compared with MI only (16.3 ± 6.6 versus 1.7 ± 0.6 cycle times values, P < 0.05), and were similar by 21 days post-MI. Temporal changes in fibroblast function and smooth muscle actin (SMA) expression relative to referent control (n = 5) occurred with MI. CHAM induced increases in fibroblast proliferation, migration, and SMA expression—indicative of fibroblast transformation. By 21 days, CHAM reduced LV dilation (diastolic volume: 75 ± 2 versus 97 ± 4 ml) and increased function (ejection fraction: 48 ± 2% versus 38 ± 2%) compared with MI only (both P < 0.05). This study identified that effects on macrophage and fibroblast differentiation occurred with injection of biocomposite material within the MI, which translated into reduced adverse LV remodeling. These unique findings demonstrate that biomaterial injections impart biologic effects upon the MI remodeling process over any biophysical effects.